Saudi Arabia Gene Synthesis Research Use Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
Description
Saudi Arabia Gene Synthesis Research Use Market Overview
The Saudi Arabia Gene Synthesis Research Use Market is valued at USD 100 million, based on a five-year historical analysis of the broader gene and DNA synthesis landscape in the country and normalization against specialist country estimates. This growth is primarily driven by advancements in biotechnology, increasing investments in research and development under Vision 2030, and a growing demand for synthetic biology applications across sectors such as healthcare, vaccines, precision medicine, agricultural biotechnology, and environmental applications. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their robust research infrastructure, presence of leading academic institutions, and government support for biotechnology initiatives. Riyadh leads with major universities and pharmaceutical companies, while the Western Province around Jeddah and the KAUST campus in Thuwal hosts the Saudi Vaccine and Biomanufacturing Center and other advanced genomics and biomanufacturing facilities, reinforcing the concentration of biotechnology firms and research organizations in these regions. The regulatory environment for gene and genome-related activities is shaped by instruments such as the Saudi Human Genome Program Governance Framework issued under the Ministry of Health and King Abdulaziz City for Science and Technology, as well as the Law of Ethics of Research on Living Creatures (National Committee of Bioethics Regulations, King Abdulaziz City for Science and Technology, 2010), which sets binding requirements for ethical review, biosafety, informed consent, and data protection in genetics and biotechnology research. These instruments, together with funding mechanisms under Vision 2030 and the National Biotechnology Strategy, channel government support, competitive grants, and institutional incentives that promote adoption of gene synthesis technologies by public and private research institutions.
Saudi Arabia Gene Synthesis Research Use Market Segmentation
By Service Type: The service type segmentation includes various offerings such as Gene Fragment Synthesis, Synthetic Genes, Oligonucleotide/Primer Synthesis, Gene Library Synthesis, Custom Cloning, and others. Among these, Gene Fragment Synthesis is an important sub-segment because of its role in assembling longer constructs and supporting diverse research workflows in gene editing and synthetic biology. However, international benchmarks for Saudi Arabia indicate that oligonucleotide synthesis currently accounts for the largest revenue share within DNA and gene synthesis services, with gene synthesis identified as the most rapidly growing segment, reflecting strong demand for customized constructs for vaccines, diagnostics, and therapeutic research. The demand for customized gene fragments and full-length synthetic genes has surged as researchers seek tailored solutions for vaccine development, biosimilar development, and precision medicine projects. By Method: The method segmentation encompasses various techniques used in gene synthesis, including PCR-based Enzyme Synthesis, Chip-based Synthesis, Solid-phase Synthesis, and Hybrid/Enzymatic DNA Assembly Platforms. The PCR-based Enzyme Synthesis method remains widely adopted in academic and routine research settings due to its established protocols, flexibility, and cost-effectiveness for many standard applications. At the same time, chip-based synthesis has emerged as a leading technology in the Saudi Arabia gene synthesis market, particularly for high-throughput and large-scale projects, supported by major institutions such as KAUST and the Saudi Vaccine and Biomanufacturing Center that are investing in advanced platforms aligned with Vision 2030 research and biomanufacturing goals. Solid-phase synthesis and hybrid/enzymatic DNA assembly platforms are also gaining traction for specialized pharmaceutical, vaccine, and complex construct applications where high fidelity and customization are critical.
Saudi Arabia Gene Synthesis Research Use Market Market Opportunities
The Saudi Arabia Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as GenScript Biotech, Integrated DNA Technologies (IDT), Thermo Fisher Scientific, Eurofins Genomics, Twist Bioscience, Bioneer, Genewiz (Azenta Life Sciences), ATUM, DNA Script, Codex DNA (Codexis / Telesis Bio – as relevant), LGC Biosearch Technologies, Jena Bioscience, BGI Genomics, Local / Regional Players (e.g., SPIMACO-aligned or KAUST-linked service labs), Contract Manufacturing & CRO Partners Serving Saudi Research Accounts contribute to innovation, geographic expansion, and service delivery in this space.
GenScript Biotech
2002 Nanjing, China
Integrated DNA Technologies (IDT)
1987 Coralville, Iowa, USA
Thermo Fisher Scientific
2006 Waltham, Massachusetts, USA
Eurofins Genomics
1990 Ebersberg, Germany
Twist Bioscience
2013 South San Francisco, California, USA
Company
Establishment Year
Headquarters
Global Gene Synthesis Revenue (Latest FY, USD Million) Revenue from Saudi Arabia / GCC (Estimated, USD Million)
3-year CAGR in Research-use Gene Synthesis Revenue (%)
Gross Margin on Gene Synthesis Services (%)
Average Order Value – Saudi Arabia Research Customers (USD)
Customer Acquisition Cost per Saudi Arabia Research Account (USD)
Saudi Arabia Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The synthetic biology market in Saudi Arabia is projected to reach $1.5 billion, driven by the rising demand for applications in healthcare, agriculture, and environmental management. The Kingdom's Vision 2030 initiative emphasizes biotechnology, aiming to diversify the economy and reduce oil dependency. This strategic focus is expected to boost investments in synthetic biology, enhancing research capabilities and fostering innovation in gene synthesis technologies. Rising Investment in Biotechnology Research: Saudi Arabia's biotechnology sector is anticipated to receive over $500 million in investments, reflecting a growing commitment to research and development. The government has established several funding programs to support biotech startups and research institutions. This influx of capital is crucial for advancing gene synthesis technologies, enabling local firms to compete on a global scale and contribute to the development of novel therapeutic solutions. Supportive Government Initiatives for Research and Development: The Saudi government has implemented various initiatives to promote biotechnology research, including the establishment of the King Abdulaziz City for Science and Technology (KACST). The government plans to allocate approximately $200 million to support biotech research projects. These initiatives aim to create a conducive environment for innovation, facilitating collaborations between academia and industry, and ultimately enhancing the gene synthesis landscape in the region.
Market Challenges
High Costs Associated with Gene Synthesis: The gene synthesis process can be prohibitively expensive, with costs ranging from $0.10 to $0.50 per base pair. This financial barrier limits access for many research institutions and startups in Saudi Arabia. As a result, the high costs hinder the widespread adoption of gene synthesis technologies, particularly among smaller entities that may lack sufficient funding to invest in advanced biotechnology solutions. Limited Awareness Among Potential End-Users: Despite the potential benefits of gene synthesis, awareness remains low among potential end-users in Saudi Arabia. A survey indicated that only 30% of researchers in the life sciences were familiar with gene synthesis applications. This lack of awareness can impede market growth, as many researchers may not fully understand the advantages of integrating gene synthesis into their projects, limiting demand for these technologies.
Saudi Arabia Gene Synthesis Research Use Market Future Outlook
The future of the gene synthesis market in Saudi Arabia appears promising, driven by advancements in synthetic biology and increasing government support. As the nation continues to invest in biotechnology, the integration of innovative technologies such as CRISPR and AI is expected to enhance gene synthesis processes. Furthermore, collaborations between academic institutions and industry players will likely foster a more robust research environment, paving the way for breakthroughs in personalized medicine and sustainable biomanufacturing practices.
Market Opportunities
Expansion of Personalized Medicine: The growing focus on personalized medicine presents significant opportunities for gene synthesis in Saudi Arabia. With an estimated 60% of healthcare providers exploring personalized treatment options, gene synthesis technologies can facilitate the development of tailored therapies, improving patient outcomes and driving demand for innovative solutions in the healthcare sector. Collaborations with Academic Institutions: Partnerships between biotechnology firms and academic institutions are crucial for advancing gene synthesis research. It is projected that over 40 collaborative projects will be initiated, focusing on gene synthesis applications. These collaborations can enhance knowledge transfer, foster innovation, and ultimately lead to the commercialization of new technologies, benefiting both sectors.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Saudi Arabia Gene Synthesis Research Use Market is valued at USD 100 million, based on a five-year historical analysis of the broader gene and DNA synthesis landscape in the country and normalization against specialist country estimates. This growth is primarily driven by advancements in biotechnology, increasing investments in research and development under Vision 2030, and a growing demand for synthetic biology applications across sectors such as healthcare, vaccines, precision medicine, agricultural biotechnology, and environmental applications. Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their robust research infrastructure, presence of leading academic institutions, and government support for biotechnology initiatives. Riyadh leads with major universities and pharmaceutical companies, while the Western Province around Jeddah and the KAUST campus in Thuwal hosts the Saudi Vaccine and Biomanufacturing Center and other advanced genomics and biomanufacturing facilities, reinforcing the concentration of biotechnology firms and research organizations in these regions. The regulatory environment for gene and genome-related activities is shaped by instruments such as the Saudi Human Genome Program Governance Framework issued under the Ministry of Health and King Abdulaziz City for Science and Technology, as well as the Law of Ethics of Research on Living Creatures (National Committee of Bioethics Regulations, King Abdulaziz City for Science and Technology, 2010), which sets binding requirements for ethical review, biosafety, informed consent, and data protection in genetics and biotechnology research. These instruments, together with funding mechanisms under Vision 2030 and the National Biotechnology Strategy, channel government support, competitive grants, and institutional incentives that promote adoption of gene synthesis technologies by public and private research institutions.
Saudi Arabia Gene Synthesis Research Use Market Segmentation
By Service Type: The service type segmentation includes various offerings such as Gene Fragment Synthesis, Synthetic Genes, Oligonucleotide/Primer Synthesis, Gene Library Synthesis, Custom Cloning, and others. Among these, Gene Fragment Synthesis is an important sub-segment because of its role in assembling longer constructs and supporting diverse research workflows in gene editing and synthetic biology. However, international benchmarks for Saudi Arabia indicate that oligonucleotide synthesis currently accounts for the largest revenue share within DNA and gene synthesis services, with gene synthesis identified as the most rapidly growing segment, reflecting strong demand for customized constructs for vaccines, diagnostics, and therapeutic research. The demand for customized gene fragments and full-length synthetic genes has surged as researchers seek tailored solutions for vaccine development, biosimilar development, and precision medicine projects. By Method: The method segmentation encompasses various techniques used in gene synthesis, including PCR-based Enzyme Synthesis, Chip-based Synthesis, Solid-phase Synthesis, and Hybrid/Enzymatic DNA Assembly Platforms. The PCR-based Enzyme Synthesis method remains widely adopted in academic and routine research settings due to its established protocols, flexibility, and cost-effectiveness for many standard applications. At the same time, chip-based synthesis has emerged as a leading technology in the Saudi Arabia gene synthesis market, particularly for high-throughput and large-scale projects, supported by major institutions such as KAUST and the Saudi Vaccine and Biomanufacturing Center that are investing in advanced platforms aligned with Vision 2030 research and biomanufacturing goals. Solid-phase synthesis and hybrid/enzymatic DNA assembly platforms are also gaining traction for specialized pharmaceutical, vaccine, and complex construct applications where high fidelity and customization are critical.
Saudi Arabia Gene Synthesis Research Use Market Market Opportunities
The Saudi Arabia Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as GenScript Biotech, Integrated DNA Technologies (IDT), Thermo Fisher Scientific, Eurofins Genomics, Twist Bioscience, Bioneer, Genewiz (Azenta Life Sciences), ATUM, DNA Script, Codex DNA (Codexis / Telesis Bio – as relevant), LGC Biosearch Technologies, Jena Bioscience, BGI Genomics, Local / Regional Players (e.g., SPIMACO-aligned or KAUST-linked service labs), Contract Manufacturing & CRO Partners Serving Saudi Research Accounts contribute to innovation, geographic expansion, and service delivery in this space.
GenScript Biotech
2002 Nanjing, China
Integrated DNA Technologies (IDT)
1987 Coralville, Iowa, USA
Thermo Fisher Scientific
2006 Waltham, Massachusetts, USA
Eurofins Genomics
1990 Ebersberg, Germany
Twist Bioscience
2013 South San Francisco, California, USA
Company
Establishment Year
Headquarters
Global Gene Synthesis Revenue (Latest FY, USD Million) Revenue from Saudi Arabia / GCC (Estimated, USD Million)
3-year CAGR in Research-use Gene Synthesis Revenue (%)
Gross Margin on Gene Synthesis Services (%)
Average Order Value – Saudi Arabia Research Customers (USD)
Customer Acquisition Cost per Saudi Arabia Research Account (USD)
Saudi Arabia Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The synthetic biology market in Saudi Arabia is projected to reach $1.5 billion, driven by the rising demand for applications in healthcare, agriculture, and environmental management. The Kingdom's Vision 2030 initiative emphasizes biotechnology, aiming to diversify the economy and reduce oil dependency. This strategic focus is expected to boost investments in synthetic biology, enhancing research capabilities and fostering innovation in gene synthesis technologies. Rising Investment in Biotechnology Research: Saudi Arabia's biotechnology sector is anticipated to receive over $500 million in investments, reflecting a growing commitment to research and development. The government has established several funding programs to support biotech startups and research institutions. This influx of capital is crucial for advancing gene synthesis technologies, enabling local firms to compete on a global scale and contribute to the development of novel therapeutic solutions. Supportive Government Initiatives for Research and Development: The Saudi government has implemented various initiatives to promote biotechnology research, including the establishment of the King Abdulaziz City for Science and Technology (KACST). The government plans to allocate approximately $200 million to support biotech research projects. These initiatives aim to create a conducive environment for innovation, facilitating collaborations between academia and industry, and ultimately enhancing the gene synthesis landscape in the region.
Market Challenges
High Costs Associated with Gene Synthesis: The gene synthesis process can be prohibitively expensive, with costs ranging from $0.10 to $0.50 per base pair. This financial barrier limits access for many research institutions and startups in Saudi Arabia. As a result, the high costs hinder the widespread adoption of gene synthesis technologies, particularly among smaller entities that may lack sufficient funding to invest in advanced biotechnology solutions. Limited Awareness Among Potential End-Users: Despite the potential benefits of gene synthesis, awareness remains low among potential end-users in Saudi Arabia. A survey indicated that only 30% of researchers in the life sciences were familiar with gene synthesis applications. This lack of awareness can impede market growth, as many researchers may not fully understand the advantages of integrating gene synthesis into their projects, limiting demand for these technologies.
Saudi Arabia Gene Synthesis Research Use Market Future Outlook
The future of the gene synthesis market in Saudi Arabia appears promising, driven by advancements in synthetic biology and increasing government support. As the nation continues to invest in biotechnology, the integration of innovative technologies such as CRISPR and AI is expected to enhance gene synthesis processes. Furthermore, collaborations between academic institutions and industry players will likely foster a more robust research environment, paving the way for breakthroughs in personalized medicine and sustainable biomanufacturing practices.
Market Opportunities
Expansion of Personalized Medicine: The growing focus on personalized medicine presents significant opportunities for gene synthesis in Saudi Arabia. With an estimated 60% of healthcare providers exploring personalized treatment options, gene synthesis technologies can facilitate the development of tailored therapies, improving patient outcomes and driving demand for innovative solutions in the healthcare sector. Collaborations with Academic Institutions: Partnerships between biotechnology firms and academic institutions are crucial for advancing gene synthesis research. It is projected that over 40 collaborative projects will be initiated, focusing on gene synthesis applications. These collaborations can enhance knowledge transfer, foster innovation, and ultimately lead to the commercialization of new technologies, benefiting both sectors.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
89 Pages
- 1. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Size (in USD Bn), 2019-2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing Investment in Biotechnology Research
- 3.1.2 Rising Demand for Synthetic Biology Applications
- 3.1.3 Advancements in Gene Editing Technologies
- 3.1.4 Supportive Government Initiatives and Funding
- 3.2. Restraints
- 3.2.1 High Costs of Gene Synthesis Services
- 3.2.2 Limited Awareness Among Potential Users
- 3.2.3 Regulatory Challenges in Biotechnology
- 3.2.4 Competition from Established Markets
- 3.3. Opportunities
- 3.3.1 Expansion of Biopharmaceuticals Sector
- 3.3.2 Collaborations with International Research Institutions
- 3.3.3 Growth in Personalized Medicine
- 3.3.4 Increasing Applications in Agriculture
- 3.4. Trends
- 3.4.1 Shift Towards Automation in Gene Synthesis
- 3.4.2 Emergence of CRISPR Technology
- 3.4.3 Growing Focus on Sustainable Biotechnology
- 3.4.4 Integration of AI in Gene Synthesis Processes
- 3.5. Government Regulation
- 3.5.1 Regulatory Framework for Biotechnology in Saudi Arabia
- 3.5.2 Compliance with International Standards
- 3.5.3 Ethical Guidelines for Genetic Research
- 3.5.4 Policies Supporting Biotechnology Innovation
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Segmentation, 2024
- 4.1. By Application Area (in Value %)
- 4.1.1 Pharmaceuticals
- 4.1.2 Agriculture
- 4.1.3 Industrial Biotechnology
- 4.1.4 Academic Research
- 4.1.5 Others
- 4.2. By Technology Type (in Value %)
- 4.2.1 PCR-based Synthesis
- 4.2.2 Solid-phase Synthesis
- 4.2.3 Enzymatic Synthesis
- 4.3. By End-User (in Value %)
- 4.3.1 Academic Institutions
- 4.3.2 Biopharmaceutical Companies
- 4.4. By Service Type (in Value %)
- 4.4.1 Custom Gene Synthesis
- 4.4.2 Gene Assembly Services
- 4.4.3 Gene Editing Services
- 4.5. By Pricing Tier (in Value %)
- 4.5.1 Premium Services
- 4.5.2 Standard Services
- 4.5.3 Budget Services
- 4.6. By Region (in Value %)
- 4.6.1 Central Region
- 4.6.2 Eastern Region
- 4.6.3 Western Region
- 4.6.4 Southern Region
- 4.6.5 Northern Region
- 4.6.6 Southern Border Region
- 4.6.7 Other Regions
- 5. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 Saudi Biotechnology Company
- 5.1.2 Genomics Arabia
- 5.1.3 BioTech Saudi
- 5.1.4 Al-Dar Biotechnology
- 5.1.5 Advanced Gene Technologies
- 5.2. Cross Comparison Parameters
- 5.2.1 No. of Employees
- 5.2.2 Headquarters Location
- 5.2.3 Inception Year
- 5.2.4 Revenue
- 5.2.5 Production Capacity
- 6. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Regulatory Framework
- 6.1. Biotechnology Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Size (in USD Bn), 2025-2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Saudi Arabia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Segmentation, 2030
- 8.1. By Application Area (in Value %)
- 8.2. By Technology Type (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Service Type (in Value %)
- 8.5. By Pricing Tier (in Value %)
- 8.6. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
